Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Has Accuray Become the Perfect Stock?

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want?

One thing's for sure: You'll never discover truly great investments unless you actively look for them. Let's discuss the ideal qualities of a perfect stock, then decide if Accuray (Nasdaq: ARAY  ) fits the bill.

The quest for perfection
Stocks that look great based on one factor may prove horrible elsewhere, making due diligence a crucial part of your investing research. The best stocks excel in many different areas, including these important factors:

  • Growth. Expanding businesses show healthy revenue growth. While past growth is no guarantee that revenue will keep rising, it's certainly a better sign than a stagnant top line.
  • Margins. Higher sales mean nothing if a company can't produce profits from them. Strong margins ensure that company can turn revenue into profit.
  • Balance sheet. At debt-laden companies, banks and bondholders compete with shareholders for management's attention. Companies with strong balance sheets don't have to worry about the distraction of debt.
  • Money-making opportunities. Return on equity helps measure how well a company is finding opportunities to turn its resources into profitable business endeavors.
  • Valuation. You can't afford to pay too much for even the best companies. By using normalized figures, you can see how a stock's simple earnings multiple fits into a longer-term context.
  • Dividends. For tangible proof of profits, a check to shareholders every three months can't be beat. Companies with solid dividends and strong commitments to increasing payouts treat shareholders well.

With those factors in mind, let's take a closer look at Accuray.


What We Want to See


Pass or Fail?

Growth 5-Year Annual Revenue Growth > 15% 26.6% Pass
  1-Year Revenue Growth > 12% 83.8% Pass
Margins Gross Margin > 35% 34.6% Fail
  Net Margin > 15% (20%) Fail
Balance Sheet Debt to Equity < 50% 36.2% Pass
  Current Ratio > 1.3 1.81 Pass
Opportunities Return on Equity > 15% (41.5%) Fail
Valuation Normalized P/E < 20 NM NM
Dividends Current Yield > 2% 0% Fail
  5-Year Dividend Growth > 10% 0% Fail
  Total Score   4 out of 9

Source: S&P Capital IQ. NM = not meaningful due to negative earnings. Total score = number of passes.

Since we looked at Accuray last year, the company has kept its four-point score. The medical device maker has seen huge sales growth in the past year, but it came from an acquisition and thus far hasn't translated into consistent profitability.

The field of robotics has revolutionized the medical industry, and a host of companies are trying to take advantage. While Intuitive Surgical (Nasdaq: ISRG  ) has used its da Vinci surgical systems to dominate prostate procedures and MAKO Surgical (Nasdaq: MAKO  ) has focused on orthopedic joint procedures, Accuray now has two products -- its legacy CyberKnife, and the TomoTherapy line of systems it obtained in an acquisition almost a year ago. Both are used to fight cancer.

But Accuray can expect to see more direct competition in the years to come. So far, Intuitive, MAKO, and Hansen Medical (Nasdaq: HNSN  ) have largely stayed out of one another's way, with Hansen specializing in catheter placement. But Varian Medical Systems (NYSE: VAR  ) goes head-to-head in cancer treatment with devices designed to use radiotherapy and radiosurgical methods.

For Accuray to keep advancing, it needs to demonstrate its competitive advantage over Varian and other medical equipment makers. Given that Varian is profitable and Accuray isn't, that could well prove to be an uphill climb -- but if Accuray can follow the path of pioneer Intuitive Surgical, then it could get a lot closer to perfection eventually.

Keep searching
No stock is a sure thing, but some stocks are a lot closer to perfect than others. By looking for the perfect stock, you'll go a long way toward improving your investing prowess and learning how to separate the best investments from the rest.

Accuray isn't the perfect stock, but we've got some ideas you may like better. Let me invite you to learn about three smart long-term stock plays in the Fool's latest special report. It's yours for the taking and is absolutely free, but don't miss out -- click here and read it today.

Click here to add Accuray to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.

Fool contributor Dan Caplinger doesn't own shares of the companies mentioned in this article. The Motley Fool owns shares of Intuitive Surgical and MAKO Surgical. Motley Fool newsletter services have recommended buying shares of MAKO Surgical and Intuitive Surgical. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1887267, ~/Articles/ArticleHandler.aspx, 5/31/2016 8:26:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 3 days ago Sponsored by:
DOW 17,873.22 44.93 0.25%
S&P 500 2,099.06 8.96 0.43%
NASD 4,933.51 0.00 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/27/2016 4:00 PM
ARAY $5.39 Down -0.03 -0.55%
Accuray, Inc. CAPS Rating: ***
HNSN $3.98 Up +0.02 +0.51%
Hansen Medical CAPS Rating: *
ISRG $636.65 Down -0.55 -0.09%
Intuitive Surgical CAPS Rating: ****
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****
VAR $82.05 Up +0.15 +0.18%
Varian Medical Sys… CAPS Rating: ***